Intensity Therapeutics, Inc. (INTS) fundamentals chart

INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$3.08−0.02 (-0.65%)

Close on Nov 13, 2026Market cap $10.06MP/E –Yield –

Fundamental chart

Pick a measure to chart its full history

-$11.97MFY2025

See a number that looks wrong?